References
1. Virani SS, Alonso A,
Benjamin EJ, Bittencourt MS, Callaway CW, Carson AP, et al. Heart
disease and stroke statistics—2020 update: a report from the American
Heart Association. Circulation. 2020; E139–E596.
2. Badhwar V, Scott Rankin J,
Damiano RJ, Marc Gillinov A, Bakaeen FG, Edgerton JR, et al. The Society
of Thoracic Surgeons 2017 Clinical Practice Guidelines for the Surgical
Treatment of Atrial Fibrillation. The Annals of Thoracic Surgery. 2017.
pp. 329–341.
doi:10.1016/j.athoracsur.2016.10.076
3. Singh SN, Singh BN, Reda
DJ, Fye CL, Ezekowitz MD, Fletcher RD, et al. Comparison of sotalol
versus amiodarone in maintaining stability of sinus rhythm in patients
with atrial fibrillation (Sotalol-Amiodarone Fibrillation Efficacy Trial
[Safe-T]). Am J Cardiol. 2003;92: 468–472.
4. Doyle JF, Ho KM. Benefits
and risks of long-term amiodarone therapy for persistent atrial
fibrillation: a meta-analysis. Mayo Clin Proc. 2009;84: 234–242.
5. Andrade JG, Wells GA,
Deyell MW, Bennett M, Essebag V, Champagne J, et al. Cryoablation or
Drug Therapy for Initial Treatment of Atrial Fibrillation. N Engl J Med.
2021;384: 305–315.
6. Bonanno C, Paccanaro M, La
Vecchia L, Ometto R, Fontanelli A. Efficacy and safety of catheter
ablation versus antiarrhythmic drugs for atrial fibrillation: a
meta-analysis of randomized trials. J Cardiovasc Med . 2010;11:
408–418.
7. Gaita F, Scaglione M,
Battaglia A, Matta M, Gallo C, Galatà M, et al. Very long-term outcome
following transcatheter ablation of atrial fibrillation. Are results
maintained after 10 years of follow up? Europace. 2018;20: 443–450.
8. Scherr D, Khairy P,
Miyazaki S, Aurillac-Lavignolle V, Pascale P, Wilton SB, et al.
Five-year outcome of catheter ablation of persistent atrial fibrillation
using termination of atrial fibrillation as a procedural endpoint. Circ
Arrhythm Electrophysiol. 2015;8: 18–24.
9. Ganesan AN, Shipp NJ,
Brooks AG, Kuklik P, Lau DH, Lim HS, et al. Long-term outcomes of
catheter ablation of atrial fibrillation: a systematic review and
meta-analysis. J Am Heart Assoc. 2013;2: e004549.
10. Calkins H, Hindricks G,
Cappato R, Kim Y-H, Saad EB, Aguinaga L, et al. 2017
HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and
surgical ablation of atrial fibrillation. Europace. 2018;20: e1–e160.
11. Cox JL, Schuessler RB,
D’Agostino HJ Jr, Stone CM, Chang BC, Cain ME, et al. The surgical
treatment of atrial fibrillation. III. Development of a definitive
surgical procedure. J Thorac Cardiovasc Surg. 1991;101: 569–583.
12. Weimar T, Schena S,
Bailey MS, Maniar HS, Schuessler RB, Cox JL, et al. The cox-maze
procedure for lone atrial fibrillation: a single-center experience over
2 decades. Circ Arrhythm Electrophysiol. 2012;5: 8–14.
13. Lall SC, Melby SJ,
Voeller RK, Zierer A, Bailey MS, Guthrie TJ, et al. The effect of
ablation technology on surgical outcomes after the Cox-maze procedure: A
propensity analysis. The Journal of Thoracic and Cardiovascular Surgery.
2007. pp. 389–396.
doi:10.1016/j.jtcvs.2006.10.009
14. Gaynor SL, Diodato MD,
Prasad SM, Ishii Y, Schuessler RB, Bailey MS, et al. A prospective,
single-center clinical trial of a modified Cox maze procedure with
bipolar radiofrequency ablation. The Journal of Thoracic and
Cardiovascular Surgery. 2004. pp. 535–542.
doi:10.1016/j.jtcvs.2004.02.044
15. Henn MC, Lancaster TS,
Miller JR, Sinn LA, Schuessler RB, Moon MR, et al. Late outcomes after
the Cox maze IV procedure for atrial fibrillation. J Thorac Cardiovasc
Surg. 2015;150: 1168–76, 1178.e1–2.
16. Ad N, Holmes SD,
Massimiano PS, Rongione AJ, Fornaresio LM. Long-term outcome following
concomitant mitral valve surgery and Cox maze procedure for atrial
fibrillation. J Thorac Cardiovasc Surg. 2018;155: 983–994.
17. Wu C-C, Chang J-P, Chen
M-C, Cheng C-I, Chung W-J. Long-term results of radiofrequency maze
procedure for persistent atrial fibrillation with concomitant mitral
surgery. J Thorac Dis. 2017;9: 5176–5183.
18. Khiabani AJ, MacGregor
RM, Bakir NH, Manghelli JL, Sinn LA, Maniar HS, et al. The long-term
outcomes and durability of the Cox-Maze IV procedure for atrial
fibrillation. J Thorac Cardiovasc Surg. 2020.
doi:10.1016/j.jtcvs.2020.04.100
19. Musharbash FN, Schill MR,
Sinn LA, Schuessler RB, Maniar HS, Moon MR, et al. Performance of the
Cox-maze IV procedure is associated with improved long-term survival in
patients with atrial fibrillation undergoing cardiac surgery. J Thorac
Cardiovasc Surg. 2018;155: 159–170.
20. Kneeland PP, Fang MC.
Trends in catheter ablation for atrial fibrillation in the United
States. J Hosp Med. 2009;4: E1–5.
21. Ad N, Henry L, Friehling
T, Wish M, Holmes SD. Minimally invasive stand-alone Cox-maze procedure
for patients with nonparoxysmal atrial fibrillation. Ann Thorac Surg.
2013;96: 792–8; discussion 798–9.
22. Ad N, Holmes SD,
Friehling T. Minimally Invasive Stand-Alone Cox Maze Procedure for
Persistent and Long-Standing Persistent Atrial Fibrillation:
Perioperative Safety and 5-Year Outcomes. Circ Arrhythm Electrophysiol.
2017;10.
doi:10.1161/CIRCEP.117.005352
23. Lapenna E, De Bonis M,
Giambuzzi I, Del Forno B, Ruggeri S, Cireddu M, et al. Long-term
Outcomes of Stand-Alone Maze IV for Persistent or Long-standing
Persistent Atrial Fibrillation. Ann Thorac Surg. 2020;109: 124–131.
24. MacGregor RM, Khiabani
AJ, Damiano RJ. The Surgical Treatment of Atrial Fibrillation Via Median
Sternotomy. Operative Techniques in Thoracic and Cardiovascular Surgery.
2019;24: 19–37.
25. Pet M, Robertson JO,
Bailey M, Guthrie TJ, Moon MR, Lawton JS, et al. The impact of CHADS2
score on late stroke after the Cox maze procedure. J Thorac Cardiovasc
Surg. 2013;146: 85–89.
26. Austin PC, Lee DS, Fine
JP. Introduction to the Analysis of Survival Data in the Presence of
Competing Risks. Circulation. 2016;133: 601–609.
27. Huebner M, Wolkewitz M,
Enriquez-Sarano M, Schumacher M. Competing risks need to be considered
in survival analysis models for cardiovascular outcomes. J Thorac
Cardiovasc Surg. 2017;153: 1427–1431.
28. Friberg L, Rosenqvist M,
Lip GYH. Evaluation of risk stratification schemes for ischaemic stroke
and bleeding in 182 678 patients with atrial fibrillation: the Swedish
Atrial Fibrillation cohort study. Eur Heart J. 2012;33: 1500–1510.
29. Levin R, Dolgin M, Fox C,
Gorlin R. The Criteria Committee of the New York Heart Association:
Nomenclature and Criteria for Diagnosis of Diseases of the Heart and
Great Vessels. LWW Handbooks. 1994;9: 344.
30. January CT, Wann LS,
Alpert JS, Calkins H, Cigarroa JE, Cleveland JC Jr, et al. 2014
AHA/ACC/HRS guideline for the management of patients with atrial
fibrillation: executive summary: a report of the American College of
Cardiology/American Heart Association Task Force on practice guidelines
and the Heart Rhythm Society. Circulation. 2014;130: 2071–2104.
31. Saini A, Hu YL, Kasirajan
V, Han FT, Khan MZ, Wolfe L, et al. Long-term outcomes of minimally
invasive surgical ablation for atrial fibrillation: A single-center
experience. Heart Rhythm. 2017;14: 1281–1288.
32. Zheng S, Li Y, Han J,
Zhang H, Zeng W, Xu C, et al. Long-term results of a minimally invasive
surgical pulmonary vein isolation and ganglionic plexi ablation for
atrial fibrillation. PLoS One. 2013;8: e79755.
33. Prasad SM, Maniar HS,
Camillo CJ, Schuessler RB, Boineau JP, Sundt TM 3rd, et al. The Cox maze
III procedure for atrial fibrillation: long-term efficacy in patients
undergoing lone versus concomitant procedures. J Thorac Cardiovasc Surg.
2003;126: 1822–1828.
34. McCarthy PM, Gillinov AM,
Castle L, Chung M, Cosgrove D 3rd. The Cox-Maze procedure: the Cleveland
Clinic experience. Semin Thorac Cardiovasc Surg. 2000;12: 25–29.
35. Damiano RJ Jr, Lawrance
CP, Saint LL, Henn MC, Sinn LA, Kruse J, et al. Detection of Atrial
Fibrillation After Surgical Ablation: Conventional Versus Continuous
Monitoring. Ann Thorac Surg. 2016;101: 42–7; discussion 47–8.